PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions

AlloVir, Inc. (ALVR)

Equity · Currency in USD · Last updated Nov 22, 2023
SummaryFinancials

Company Info

ISINUS0198181036
CUSIP019818103
SectorHealthcare
IndustryBiotechnology

Highlights

Market Cap$187.06M
EPS-$1.67
Gross Profit (TTM)$165.00K
EBITDA (TTM)-$177.59M
Year Range$1.31 - $7.84
Target Price$19.50
Short %17.65%
Short Ratio18.97

Share Price Chart


Loading data...

Performance

The chart shows the growth of an initial investment of $10,000 in AlloVir, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-60.00%-40.00%-20.00%0.00%20.00%40.00%JuneJulyAugustSeptemberOctoberNovember
-63.67%
9.48%
ALVR (AlloVir, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with ALVR

AlloVir, Inc.

Return

AlloVir, Inc. had a return of -69.59% year-to-date (YTD) and -78.86% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date-69.59%18.20%
1 month3.31%7.43%
6 months-63.64%9.47%
1 year-78.86%14.89%
5 years (annualized)N/A11.39%
10 years (annualized)N/A9.68%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2023-12.69%9.59%-9.81%-3.24%-4.86%-31.31%-30.23%

Risk-Adjusted Performance

This table presents a comparison of risk-adjusted performance metrics for AlloVir, Inc. (ALVR) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
ALVR
AlloVir, Inc.
-0.81
^GSPC
S&P 500
1.01

Sharpe Ratio

The current AlloVir, Inc. Sharpe ratio is -0.81. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.00JuneJulyAugustSeptemberOctoberNovember
-0.81
1.02
ALVR (AlloVir, Inc.)
Benchmark (^GSPC)

Dividend History


AlloVir, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-96.67%
-5.72%
ALVR (AlloVir, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the AlloVir, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the AlloVir, Inc. was 97.14%, occurring on Oct 27, 2023. The portfolio has not yet recovered.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-97.14%Dec 7, 2020726Oct 27, 2023
-50.7%Aug 12, 202024Sep 15, 202056Dec 3, 202080
-1.93%Jul 31, 20201Jul 31, 20201Aug 3, 20202

Volatility Chart

The current AlloVir, Inc. volatility is 30.57%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%60.00%JuneJulyAugustSeptemberOctoberNovember
30.57%
4.24%
ALVR (AlloVir, Inc.)
Benchmark (^GSPC)

Recent discussions